Sofgen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOFGEN PHARMS
SOFGEN PHARMS has four approved drugs.
Summary for Sofgen Pharms
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Sofgen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sofgen Pharms | NIMODIPINE | nimodipine | CAPSULE;ORAL | 201832-001 | Jul 24, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sofgen Pharms | PROGESTERONE | progesterone | CAPSULE;ORAL | 200456-002 | Sep 28, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sofgen Pharms | IBUPROFEN | ibuprofen | CAPSULE;ORAL | 203599-001 | Sep 7, 2016 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sofgen Pharms | OMEGA-3-ACID ETHYL ESTERS | omega-3-acid ethyl esters | CAPSULE;ORAL | 211355-001 | Jul 10, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sofgen Pharms | PROGESTERONE | progesterone | CAPSULE;ORAL | 200456-001 | Sep 28, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
